Viewing Study NCT06326502


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2026-02-22 @ 5:24 PM
Study NCT ID: NCT06326502
Status: RECRUITING
Last Update Posted: 2024-03-27
First Post: 2024-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
Sponsor: Etnova Therapeutics Corp.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
None Advanced Hepatocellular Carcinoma View
None Liver Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HCC View